Fairvalue-Calculator Fairvalue-Calculator
EN DE

Jianzhijia Pharmaceutical Chain Group (605266) Fair Value & Analysis

Healthcare · CN · Market cap 2.6B CNY

Price¥15.59
Fair Value¥22.31
Upside+43.1%
Quality95/100
Evidence: High Range ¥15.10 – ¥33.06

Fair value as of: Jun 24, 2026

Analysis

Jianzhijia Pharmaceutical Chain Group (605266) currently trades at ¥15.59, while our model-based Fair Value estimate is ¥22.31 — implying the stock looks roughly 43.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Jianzhijia Pharmaceutical Chain Group Co., Ltd. engages in the pharmaceutical retail business in China. The company offers pharmaceuticals, health foods, personal care products, household health products, convenience foods, and daily consumables through offline community professional pharmacies, convenience stores, community clinics, Chinese medicine clinics, and physical examination centers in both online and offline ways. The company was formerly known as Yunnan Jianzhijia Health-Chain Co., Ltd. and changed its name to Jianzhijia Pharmaceutical Chain Group Co., Ltd. in September 2022. Jianzhijia Pharmaceutical Chain Group Co., Ltd. was founded in 1998 and is based in Kunming, China.

Open the full interactive analysis →

Similar stocks

JD Health International Inc (JDHIF) +920% Alibaba Health Information Technology Limited (ALBBY) -19% Raia Drogasil S.A (RADL3) -8% Yifeng Pharmacy Chain Co (603939) +5% Clicks Group (CLCGY) +23% Sugi Holdings (SGIPF) +295%

Frequently asked questions

Is Jianzhijia Pharmaceutical Chain Group (605266) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥22.31 versus a price of ¥15.59 — about +43% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 605266?
Our 21-model fair value for Jianzhijia Pharmaceutical Chain Group is ¥22.31 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥15.59.
What is the quality score of 605266?
Jianzhijia Pharmaceutical Chain Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.